Skip to main content
Skip to footer
Home
About
About
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Pipeline
Pipeline
Vidofludimus Calcium
IMU-856
IMU-381
News
News Releases
Photo Corner
Video Corner
Publications
Investors
IR Home
News Releases
Events and Presentations
Stock Information
Financials and SEC Filings
Corporate Governance
IR Contact
Career
Contact
Home
About
About
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Pipeline
Pipeline
Vidofludimus Calcium
IMU-856
IMU-381
News
News Releases
Photo Corner
Video Corner
Publications
Investors
IR Home
News Releases
Events and Presentations
Stock Information
Financials and SEC Filings
Corporate Governance
IR Contact
Career
Contact
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2026
Thursday, February 5, 2026 – Saturday, February 7, 2026
Poster ACTRIMS 2026 – Effect of Vidofludimus Calcium on MRI Outcomes in PMS
Poster ACTRIMS 2026 – Effect of Vidofludimus Calcium on Anti EBV T-cell Receptor Repertoire in PMS
Next Post
Structural Tuning of Vidofludimus for High-Efficacy NR4A Agonism
Home – 2
About
Pipeline
News
Publications
Investors
Career
Contact
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Vidofludimus Calcium
IMU-856
IMU-381
IR Home
News Releases
Events and Presentations
Stock Informations
Financials and SEC Filings
Corporate Governance
IR Contact
Search
Search